AXT107
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AXT107, covering 2024-03-22 to 2024-05-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD) [Phase 1, Phase 2]